CMV pp86 Inhibitors

CMV pp86, also known as UL86, is a multifunctional protein crucial for the replication of human cytomegalovirus (CMV). It plays a pivotal role in several aspects of the CMV replication cycle, including viral DNA synthesis, assembly, and egress. As a key component of the virion tegument layer, pp86 is involved in the packaging of viral particles and their transport within the host cell. Additionally, pp86 interacts with various cellular and viral proteins, influencing the manipulation of host immune responses, gene expression, and cell cycle progression. Its contributions to CMV pathogenesis make pp86 a target of interest for antiviral strategies.

The significance of CMV pp86 inhibitors lies in their ability to disrupt the CMV replication cycle, offering insights into both the virus's biology and the development of antiviral therapies. Inhibitors targeting pp86 could hinder viral replication, particle assembly, and immune evasion mechanisms, curbing CMV's ability to establish persistent infections. Moreover, given the central role of pp86 in multiple stages of the viral life cycle, inhibitors could shed light on essential host-virus interactions that contribute to CMV's pathogenicity.